How does the company's current valuation (EV/Revenue, P/E, EV/EBITDA) compare to its historical averages and to peers?
Valuation snapshot – As of the latest market close (early September 2025) ChargePoint trades around $12 – $13 per share, giving it an enterprise value of roughly $7.5 bn. With FY 2025 revenue of ≈$1.0 bn, the EV/Revenue ratio sits near 7.5‑8.0×. Historically, ChargePoint has oscillated between 5‑6× (when the charging network was in a rapid‑deployment phase) and 9‑10× (during hype‑driven rallies). The current multiple is therefore slightly above its long‑term mean, reflecting optimism about the FY 2026 rollout but also a modest premium to historical norms.
Because the company has yet to generate consistent profitability, its price‑to‑earnings (P/E) is still “N/A” (negative earnings over the past twelve months). The EV/EBITDA metric is similarly distorted – EBITDA is marginally negative, yielding an implied EV/EBITDA of > 30× (or “not meaningful”). By contrast, peer EV‑charging operators such as Blink (EV/Revenue ≈ 3‑4×), EVgo (≈ 5‑6×) and the broader Tesla‑Supercharger segment (≈ 2‑3×) trade at materially lower revenue multiples, while they have moved into positive EBITDA territory. In short, ChargePoint is valued at a premium to both its own historical averages and to the core peer set, mainly on the back of growth expectations rather than earnings fundamentals.
Trading implications – The elevated valuation makes the stock vulnerable to a valuation correction if FY 2026 Q2 results miss consensus on revenue growth or cash‑burn reduction. Technically, the price is respecting a 50‑day simple moving average around $13 and a trend‑line resistance near $13.5; a break below the 50‑day MA could trigger a short‑term sell‑off toward the $11‑12 support zone. Conversely, a beat‑and‑raise on revenue and a clear path to EBITDA positivity could justify a risk‑on long with a target near the $15‑16 range, aligning the EV/Revenue multiple back toward the 6‑7× historical mean. Given the current premium, many traders may favor a wait‑and‑see stance—monitoring the September 3 earnings call for concrete guidance on cash‑flow improvement before committing significant capital.